In addition, there were significant differences in the immune subtypes of ASB16-AS1 in BRCA (p <0.001), LIHC (p =0.001), LUAD (p =0.008), and UCEC (p =0.021), which partially explains the prognostic role of ASB16-AS1 in different cancer types (Figure 6d). The gene discussed is ASB16; the disease is cancer.